JP2022520779A5 - - Google Patents

Info

Publication number
JP2022520779A5
JP2022520779A5 JP2021546842A JP2021546842A JP2022520779A5 JP 2022520779 A5 JP2022520779 A5 JP 2022520779A5 JP 2021546842 A JP2021546842 A JP 2021546842A JP 2021546842 A JP2021546842 A JP 2021546842A JP 2022520779 A5 JP2022520779 A5 JP 2022520779A5
Authority
JP
Japan
Prior art keywords
phenol
cyclodextrin
formulation
approximately
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021546842A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022520779A (ja
JP7455852B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/015690 external-priority patent/WO2020167476A1/en
Publication of JP2022520779A publication Critical patent/JP2022520779A/ja
Publication of JP2022520779A5 publication Critical patent/JP2022520779A5/ja
Application granted granted Critical
Publication of JP7455852B2 publication Critical patent/JP7455852B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021546842A 2019-02-15 2020-01-29 注射可能なフェノール製剤およびその使用の方法 Active JP7455852B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962806188P 2019-02-15 2019-02-15
US62/806,188 2019-02-15
PCT/US2020/015690 WO2020167476A1 (en) 2019-02-15 2020-01-29 Injectable phenol formulations and methods of their use

Publications (3)

Publication Number Publication Date
JP2022520779A JP2022520779A (ja) 2022-04-01
JP2022520779A5 true JP2022520779A5 (cg-RX-API-DMAC10.html) 2022-11-08
JP7455852B2 JP7455852B2 (ja) 2024-03-26

Family

ID=72042651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021546842A Active JP7455852B2 (ja) 2019-02-15 2020-01-29 注射可能なフェノール製剤およびその使用の方法

Country Status (6)

Country Link
US (3) US10959962B2 (cg-RX-API-DMAC10.html)
EP (1) EP3923916A4 (cg-RX-API-DMAC10.html)
JP (1) JP7455852B2 (cg-RX-API-DMAC10.html)
CA (1) CA3129648A1 (cg-RX-API-DMAC10.html)
MX (1) MX2021009777A (cg-RX-API-DMAC10.html)
WO (1) WO2020167476A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112691091A (zh) * 2021-01-09 2021-04-23 胡宝贤 低浓度石炭酸的新应用
WO2023102496A1 (en) * 2021-12-03 2023-06-08 Path Encapsulated pharmaceutical compositions, related methods of making, and related methods of treatment
WO2025235121A1 (en) * 2024-05-07 2025-11-13 Teclison, Inc. Tirapazamine compositions and methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152320A (ja) * 1983-02-17 1984-08-31 Takeda Chem Ind Ltd 水性製剤
JPH0625056B2 (ja) 1989-06-01 1994-04-06 大幸薬品株式会社 鎮痙剤
WO2002089849A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
JP4150772B2 (ja) * 2001-09-14 2008-09-17 独立行政法人産業技術総合研究所 シクロデキストリンを含有するフェノール重合物
WO2004009064A1 (de) 2002-07-19 2004-01-29 Mestex Ag Verwendung von neurotoxischen substanzen für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
HUE034099T2 (en) * 2004-01-30 2018-01-29 Zoetis Services Llc Antimicrobial preservatives for the delivery of multidose formulations using beta-cyclodextrins for liquid dosage forms
US20120190750A1 (en) 2011-01-24 2012-07-26 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable ready to use injectable paracetamol formulation
ES2784629T3 (es) * 2011-11-29 2020-09-29 Jurox Pty Ltd Composiciones farmacéuticas inyectables estables que comprenden 2-hidroxipropil-beta-ciclodextrina y alfaxalona
US9295512B2 (en) 2013-03-15 2016-03-29 Myoscience, Inc. Methods and devices for pain management
JP6238190B2 (ja) * 2013-07-04 2017-11-29 公立大学法人大阪市立大学 コラーゲン産生促進用、エラスチン産生促進用および/またはケラチノサイト遊走促進用組成物
JP2016527250A (ja) 2013-07-22 2016-09-08 キネタ ワン リミテッド ライアビリティ カンパニーKineta One,Llc 毒素系治療用ペプチド及びその医薬組成物の眼科的使用
CN103602325B (zh) * 2013-11-18 2016-08-03 中国石油化工股份有限公司 一种延缓交联凝胶调剖剂及其制备方法
EP3171933B1 (en) 2014-07-23 2024-08-14 Landy Toth Precision chemical ablation and treatment of tissues
JP2018504420A (ja) * 2015-02-06 2018-02-15 マリナス ファーマシューティカルズ インコーポレイテッド 静注用ガナキソロン製剤ならびにてんかん重積状態および他の発作性障害の治療におけるその使用
EP3288626B8 (en) 2015-04-27 2025-12-10 Tulavi Therapeutics, Inc. Substances and compositions for use in blocking nerve regeneration
WO2017180708A1 (en) * 2016-04-12 2017-10-19 Cell and Molecular Tissue Engineering, LLC Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site

Similar Documents

Publication Publication Date Title
CA2405072C (en) Gel compositions containing metronidazole
RU2734236C2 (ru) Композиции бендамустина и циклополисахарида
CN100411624C (zh) 包含甲硝唑的含水组合物
JPH01110619A (ja) 粘膜および義歯接着性ペーストの基剤およびその製法
HU197840B (en) Process for producing synergic pharmaceutical compositions comprising amantadin and selegilin
JP2015145364A5 (cg-RX-API-DMAC10.html)
KR20090084925A (ko) 피모벤단과 사이클로덱스트린의 복합물을 포함하는 액상 제제
CN101657203B (zh) 抗癌药的组合物及递送方法
CN1809384A (zh) 提高辅酶q10传送的化学组合物及方法
CN1148174C (zh) 供局部应用的尼美舒利凝胶体系
NO20025999D0 (no) Klart, vandig anestetisk preparat
CN101410123A (zh) 低剂量的双氯芬酸和β-环糊精的制剂
CN100341577C (zh) 经皮吸收制剂
JP2006517981A (ja) 低用量コルチコステロイド組成物
KR20130113428A (ko) 음이온-양이온성 환형다당류 조성물인 벤다무스틴
ME00483B (me) Parenteralni sastav paracetamola
KR20070090205A (ko) 사이클로덱스트린과 함께 용해된 아다팔렌을 함유하는조성물
CN1373667A (zh) 非肠道使用的雌莫司汀磷酸盐和氨基酸的制剂
JP2019532112A5 (ja) 結節性痒疹を治療するための抗掻痒剤
Szente et al. Comparative bioavailability study following a single dose intravenous and buccal administration of remdesivir in rabbits
JP2017503029A (ja) ブデソニドシクロデキストリン処方物
EP2460514B1 (en) Topical pharmaceutical gel compositions of flurbiprofen, glucosamine and chondroitin
US11464866B2 (en) Pharmaceutical composition containing macromolecular drug
KR101690765B1 (ko) 항진균성 활성물질을 포함하는 경피 제제
CN107126564A (zh) 一种白蛋白结合型索拉非尼纳米制剂及其制备方法